[Short stature in chronic kidney disease: physiopathology and treatment with growth hormone]

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):783-91. doi: 10.1590/s0004-27302008000500010.
[Article in Portuguese]

Abstract

Growth failure is frequent and a clinically important issue in children with chronic kidney disease (CKD). Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH)--insulin-like growth factor 1 (IGF-1) axis, malnutrition, acidosis, renal bone disease and glucocorticoid associated treatment. The management of growth failure in children with CKD is complicated by the presence of other-disease related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, this therapy is still underutilized. This review shows the impact, the causes and the treatment of growth failure in children with CKD.

Publication types

  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Body Height / drug effects
  • Growth Disorders / drug therapy*
  • Growth Disorders / physiopathology
  • Human Growth Hormone / metabolism
  • Human Growth Hormone / therapeutic use*
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Kidney Failure, Chronic / complications*

Substances

  • Adrenal Cortex Hormones
  • Human Growth Hormone
  • Insulin-Like Growth Factor I